Open Access
RESIDENT’S CORNER
Implications of Erdheim-Chester disease and percutaneous renal access
Lael Stieglitz, Vernon M. Pais Jr.
Department of Surgery, Section of Urology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
Address correspondence to Dr. Vernon M. Pais Jr.,
Department of Surgery, Section of Urology, Dartmouth
Hitchcock Medical Center, 1 Medical Center Drive, Lebanon,
NH 03756 USA
Canadian Journal of Urology 2020, 27(6), 10493-10495.
Abstract
Erdheim-Chester disease (ECD) is a rare systemic
histiocytosis with urologic manifestations in a majority
of affected patients. An important manifestation is a
pronounced retroperitoneal fibrosis with reported dense
inflammatory rind surrounding the kidneys. We report a case of a patient with large stone burden necessitating
percutaneous nephrolithotomy and the implications
related to his Erdheim-Chester-related retroperitoneal
fibrotic changes. Foreknowledge of these implications may
inform perioperative counseling and surgical planning to
maximize opportunity for successful outcomes.
Keywords
nephrolithiasis, retroperitoneal fibrosis, Erdheim-Chester disease, histiocytosis
Cite This Article
APA Style
Stieglitz, L., Jr., V.M.P. (2020). Implications of Erdheim-Chester disease and percutaneous renal access. Canadian Journal of Urology, 27(6), 10493–10495.
Vancouver Style
Stieglitz L, Jr. VMP. Implications of Erdheim-Chester disease and percutaneous renal access. Can J Urology. 2020;27(6):10493–10495.
IEEE Style
L. Stieglitz and V.M.P. Jr., “Implications of Erdheim-Chester disease and percutaneous renal access,” Can. J. Urology, vol. 27, no. 6, pp. 10493–10495, 2020.
Copyright © 2020 The Canadian Journal of Urology.